OVID - Ovid Therapeutics EPS misses by $0.04 beats on revenue March, 15 2021 09:29 AM Ovid Therapeutics Inc. Ovid Therapeutics (OVID): Q4 GAAP EPS of -$0.34 misses by $0.04.Revenue of $5.7M beats by $1.54M.Press Release For further details see: Ovid Therapeutics EPS misses by $0.04, beats on revenue